Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XPO4 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | ZDHHC16 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | TFEB | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | ST6GALNAC4 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | XG | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | FOXD1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | ADAMTS2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | SMURF1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | SAMSN1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | GLIS1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |